Quipt Home Medical (QIPT) Stock Forecast, Price Target & Predictions
QIPT Stock Forecast
Quipt Home Medical stock forecast is as follows: an average price target of $6.00 (represents a 148.96% upside from QIPT’s last price of $2.41) and a rating consensus of 'Buy', based on 2 wall street analysts offering a 1-year stock forecast.
QIPT Price Target
The average price target for Quipt Home Medical (QIPT) is $6.00 based on 1-year price targets from 2 Wall Street analysts in the past 3 months, with a price target range of $6.00 to $6.00. This represents a potential 148.96% upside from QIPT's last price of $2.41.
QIPT Analyst Ratings
According to 2 Wall Street analysts, Quipt Home Medical's rating consensus is 'Buy'. The analyst rating breakdown for QIPT stock is 0 'Strong Buy' (0.00%), 2 'Buy' (100.00%), 0 'Hold' (0.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
Quipt Home Medical Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Aug 16, 2024 | Richard Close | Canaccord Genuity | - | - | 118.98% | 148.96% |
| May 17, 2024 | Richard Close | Canaccord Genuity | - | - | 150.00% | 231.95% |
The latest Quipt Home Medical stock forecast, released on Aug 16, 2024 by Richard Close from Canaccord Genuity, set a price target of $6.00, which represents a 118.98% increase from the stock price at the time of the forecast ($2.74), and a 148.96% increase from QIPT last price ($2.41).
Quipt Home Medical Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | - | 2 |
| Avg Price Target | - | - | $7.00 |
| Last Closing Price | $2.41 | $2.41 | $2.41 |
| Upside/Downside | -100.00% | -100.00% | 190.46% |
In the current month, the average price target of Quipt Home Medical stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Quipt Home Medical's last price of $2.41. This month's average price target is down NaN% compared to last quarter, and down -100.00% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| May 20, 2024 | Benchmark | Buy | Buy | Hold |
| May 17, 2024 | Canaccord Genuity | Buy | Buy | Hold |
| May 16, 2024 | Raymond James | Underperform | Downgrade |
Quipt Home Medical's last stock rating was published by Benchmark on May 20, 2024. The company gave QIPT a "Buy" rating, the same as its previous rate.
Quipt Home Medical Financial Forecast
Quipt Home Medical Revenue Forecast
| Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | $67.17M | $62.52M | - | $58.12M | $40.81M | $40.09M | $36.69M | $33.55M | $29.52M | $29.12M | $26.24M | $24.24M | $22.75M | $19.77M | $18.94M | $16.99M | $17.43M | $11.85M | $16.09M |
| Avg Forecast | $68.89M | $67.76M | $66.39M | $64.88M | $64.92M | $65.06M | $65.59M | $64.45M | $62.88M | $59.97M | $57.09M | $42.19M | $40.39M | $36.48M | $34.47M | $30.27M | $27.96M | $26.90M | $24.84M | $22.77M | $20.51M | $19.63M | $17.16M | $18.36M | $15.75M | $17.08M |
| High Forecast | $68.89M | $67.76M | $66.39M | $64.88M | $65.67M | $65.06M | $65.59M | $65.03M | $64.00M | $59.97M | $57.09M | $42.19M | $40.39M | $36.48M | $34.47M | $30.27M | $27.96M | $26.90M | $24.84M | $22.77M | $20.51M | $19.63M | $17.16M | $18.36M | $15.75M | $17.08M |
| Low Forecast | $68.89M | $67.76M | $66.39M | $64.88M | $64.18M | $65.06M | $65.59M | $63.51M | $61.79M | $59.97M | $57.09M | $42.19M | $40.39M | $36.48M | $34.47M | $30.27M | $27.96M | $26.90M | $24.84M | $22.77M | $20.51M | $19.63M | $17.16M | $18.36M | $15.75M | $17.08M |
| # Analysts | 1 | 1 | 1 | 1 | 3 | 1 | 1 | 3 | 6 | 3 | 3 | 4 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 4 | 4 | 4 |
| Surprise % | - | - | - | - | - | - | - | 1.04% | 0.99% | - | 1.02% | 0.97% | 0.99% | 1.01% | 0.97% | 0.98% | 1.04% | 0.98% | 0.98% | 1.00% | 0.96% | 0.96% | 0.99% | 0.95% | 0.75% | 0.94% |
Quipt Home Medical's average Quarter revenue forecast for Mar 24 based on 1 analysts is $65.59M, with a low forecast of $65.59M, and a high forecast of $65.59M. QIPT's average Quarter revenue forecast represents a -2.35% decrease compared to the company's last Quarter revenue of $67.17M (Dec 23).
Quipt Home Medical EBITDA Forecast
| Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 3 | 1 | 1 | 3 | 6 | 3 | 3 | 4 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 4 | 4 | 4 |
| EBITDA | - | - | - | - | - | - | - | $14.28M | $16.09M | - | $17.59M | $10.71M | $11.48M | $9.71M | $14.32M | $6.05M | $5.20M | $8.65M | $668.00K | $7.18M | $3.66M | $6.02M | $4.90M | $6.71M | $4.42M | $1.83M |
| Avg Forecast | $12.00M | $11.81M | $11.57M | $11.30M | $11.31M | $11.33M | $11.43M | $11.23M | $10.96M | $10.45M | $9.95M | $7.35M | $9.86M | $8.91M | $26.65M | $7.39M | $6.83M | $14.67M | $6.06M | $5.56M | $5.01M | $4.79M | $4.19M | $4.48M | $3.84M | $4.17M |
| High Forecast | $12.00M | $11.81M | $11.57M | $11.30M | $11.44M | $11.33M | $11.43M | $11.33M | $11.15M | $10.45M | $9.95M | $7.35M | $9.86M | $8.91M | $31.98M | $7.39M | $6.83M | $17.61M | $6.06M | $5.56M | $5.01M | $4.79M | $4.19M | $4.48M | $3.84M | $4.17M |
| Low Forecast | $12.00M | $11.81M | $11.57M | $11.30M | $11.18M | $11.33M | $11.43M | $11.06M | $10.77M | $10.45M | $9.95M | $7.35M | $9.86M | $8.91M | $21.32M | $7.39M | $6.83M | $11.74M | $6.06M | $5.56M | $5.01M | $4.79M | $4.19M | $4.48M | $3.84M | $4.17M |
| Surprise % | - | - | - | - | - | - | - | 1.27% | 1.47% | - | 1.77% | 1.46% | 1.16% | 1.09% | 0.54% | 0.82% | 0.76% | 0.59% | 0.11% | 1.29% | 0.73% | 1.26% | 1.17% | 1.50% | 1.15% | 0.44% |
1 analysts predict QIPT's average Quarter EBITDA for Mar 24 to be $11.43M, with a high of $11.43M and a low of $11.43M. This is -19.99% lower than Quipt Home Medical's previous annual EBITDA (Dec 23) of $14.28M.
Quipt Home Medical Net Income Forecast
| Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 3 | 1 | 1 | 3 | 6 | 3 | 3 | 4 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 4 | 4 | 4 |
| Net Income | - | - | - | - | - | - | - | $-602.20K | $-1.33M | - | $-9.50M | $325.00K | $1.77M | $163.00K | $5.04M | $-2.13M | $-1.50M | $6.33M | $-20.85M | $-2.97M | $-1.67M | $-2.73M | $1.16M | $-6.20M | $2.95M | $-9.55M |
| Avg Forecast | $1.25M | $355.09K | $-476.00K | $-1.47M | $-1.05M | $-466.34K | $385.62K | $-847.45K | $-96.22K | $-94.13K | $1.79M | $-1.20M | $1.17M | $1.65M | $12.09M | $1.32M | $-1.28M | $8.44M | $2.05M | $846.63K | $3.29M | $-4.68M | - | $1.71M | $6.93M | $-16.98M |
| High Forecast | $1.25M | $355.09K | $-476.00K | $-1.47M | $599.64K | $-466.34K | $395.25K | $282.48K | $-96.22K | $-94.13K | $1.79M | $-1.20M | $1.17M | $1.65M | $14.50M | $1.32M | $-1.28M | $10.13M | $2.05M | $846.63K | $3.29M | $-4.68M | - | $1.71M | $6.93M | $-16.98M |
| Low Forecast | $1.25M | $355.09K | $-476.00K | $-1.47M | $-2.40M | $-466.34K | $375.99K | $-1.69M | $-96.22K | $-94.13K | $1.79M | $-1.20M | $1.17M | $1.65M | $9.67M | $1.32M | $-1.28M | $6.75M | $2.05M | $846.63K | $3.29M | $-4.68M | - | $1.71M | $6.93M | $-16.98M |
| Surprise % | - | - | - | - | - | - | - | 0.71% | 13.78% | - | -5.31% | -0.27% | 1.51% | 0.10% | 0.42% | -1.61% | 1.17% | 0.75% | -10.18% | -3.51% | -0.51% | 0.58% | - | -3.62% | 0.43% | 0.56% |
Quipt Home Medical's average Quarter net income forecast for Mar 23 is $1.79M, with a range of $1.79M to $1.79M. QIPT's average Quarter net income forecast represents a 450.10% increase compared to the company's last Quarter net income of $325.00K (Dec 22).
Quipt Home Medical SG&A Forecast
| Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 3 | 1 | 1 | 3 | 6 | 3 | 3 | 4 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 4 | 4 | 4 |
| SG&A | - | - | - | - | - | - | - | $34.49M | $1.37M | - | $27.95M | $20.03M | $897.00K | $18.25M | $17.42M | $15.52M | $16.66M | $13.10M | $10.54M | $9.46M | $9.20M | $7.73M | $7.55M | $8.12M | $6.12M | $7.60M |
| Avg Forecast | $25.12M | $24.71M | $24.21M | $23.66M | $23.68M | $23.73M | $23.92M | $23.51M | $22.93M | $21.87M | $20.82M | $15.39M | $11.92M | $10.77M | $10.18M | $8.93M | $8.25M | $17.47M | $7.33M | $6.72M | $6.05M | $5.79M | $5.07M | $5.42M | $4.65M | $5.04M |
| High Forecast | $25.12M | $24.71M | $24.21M | $23.66M | $23.95M | $23.73M | $23.92M | $23.72M | $23.34M | $21.87M | $20.82M | $15.39M | $11.92M | $10.77M | $10.18M | $8.93M | $8.25M | $20.96M | $7.33M | $6.72M | $6.05M | $5.79M | $5.07M | $5.42M | $4.65M | $5.04M |
| Low Forecast | $25.12M | $24.71M | $24.21M | $23.66M | $23.41M | $23.73M | $23.92M | $23.16M | $22.53M | $21.87M | $20.82M | $15.39M | $11.92M | $10.77M | $10.18M | $8.93M | $8.25M | $13.97M | $7.33M | $6.72M | $6.05M | $5.79M | $5.07M | $5.42M | $4.65M | $5.04M |
| Surprise % | - | - | - | - | - | - | - | 1.47% | 0.06% | - | 1.34% | 1.30% | 0.08% | 1.69% | 1.71% | 1.74% | 2.02% | 0.75% | 1.44% | 1.41% | 1.52% | 1.33% | 1.49% | 1.50% | 1.32% | 1.51% |
Quipt Home Medical's average Quarter SG&A projection for Mar 24 is $23.92M, based on 1 Wall Street analysts, with a range of $23.92M to $23.92M. The forecast indicates a -30.65% fall compared to QIPT last annual SG&A of $34.49M (Dec 23).
Quipt Home Medical EPS Forecast
| Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 3 | 1 | 1 | 3 | 6 | 3 | 3 | 4 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 4 | 4 | 4 |
| EPS | - | - | - | - | - | - | - | $-0.02 | $-0.03 | - | $-0.26 | $0.01 | $0.05 | - | $0.15 | $-0.06 | $-0.05 | $0.20 | $-0.71 | $-0.11 | $-0.08 | $-0.13 | $0.06 | $-0.30 | $0.14 | $-0.46 |
| Avg Forecast | $0.03 | $0.01 | $-0.01 | $-0.03 | $-0.02 | $-0.01 | $0.01 | $-0.02 | $-0.00 | $-0.00 | $0.04 | $-0.03 | $0.03 | $0.04 | $0.01 | $0.03 | $-0.03 | $0.04 | $0.05 | $0.02 | $0.08 | $-0.11 | - | $0.04 | $0.16 | $-0.40 |
| High Forecast | $0.03 | $0.01 | $-0.01 | $-0.03 | $0.01 | $-0.01 | $0.01 | $0.01 | $-0.00 | $-0.00 | $0.04 | $-0.03 | $0.03 | $0.04 | $0.01 | $0.03 | $-0.03 | $0.04 | $0.05 | $0.02 | $0.08 | $-0.11 | - | $0.04 | $0.16 | $-0.40 |
| Low Forecast | $0.03 | $0.01 | $-0.01 | $-0.03 | $-0.06 | $-0.01 | $0.01 | $-0.04 | $-0.00 | $-0.00 | $0.04 | $-0.03 | $0.03 | $0.04 | $0.01 | $0.03 | $-0.03 | $0.04 | $0.05 | $0.02 | $0.08 | $-0.11 | - | $0.04 | $0.16 | $-0.40 |
| Surprise % | - | - | - | - | - | - | - | 0.77% | 13.29% | - | -6.20% | -0.36% | 1.82% | 0.13% | 25.47% | -2.06% | 1.61% | 4.87% | -14.78% | -5.54% | -1.03% | 1.18% | - | -7.46% | 0.86% | 1.15% |
According to 3 Wall Street analysts, Quipt Home Medical's projected average Quarter EPS for Mar 23 is $0.04, with a low estimate of $0.04 and a high estimate of $0.04. This represents a 319.45% increase compared to QIPT previous annual EPS of $0.01 (Dec 22).
Quipt Home Medical Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| AZYO | Elutia | - | - | 587.92% | Buy |
| TELA | TELA Bio | - | - | 315.28% | Buy |
| QIPT | Quipt Home Medical | - | - | 148.96% | Buy |
| SGHT | Sight Sciences | - | - | 124.44% | Hold |
| PROF | Profound Medical | - | - | 88.74% | Buy |
| LUNG | Pulmonx | - | - | 75.70% | Buy |
| RXST | RxSight | - | - | 56.39% | Buy |
| KIDS | OrthoPediatrics | - | - | 50.34% | Buy |
| NPCE | NeuroPace | - | - | 32.78% | Buy |
| OFIX | Orthofix Medical | - | - | 26.92% | |
| FNA | Paragon 28 | - | - | 14.54% | Buy |
| CVRX | CVRx | - | - | 9.97% | Buy |
| AORT | Artivion | - | - | 8.24% | Buy |
| SRDX | Surmodics | - | - | 0.43% | Buy |
| PRCT | PROCEPT BioRobotics | - | - | -18.45% | Buy |